Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
28513K.KS Stock Summary
Top 10 Correlated ETFs
28513K.KS
In the News
28513K.KS Financial details
Company Rating
Buy
Market Cap
59.61B
Income
122.06B
Revenue
1794.44B
Book val./share
-
Cash/share
-
Dividend
1550
Dividend %
5.11%
Employees
1.22K
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
4.53
Forward P/E
-
PEG
-0.58
P/S
0.66
P/B
0.26
P/C
-
P/FCF
-2.08
Quick Ratio
-
Current Ratio
2.98
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
4.74K
EPS next Y
-
EPS next Q
-
EPS this Y
-52.93%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
100.65%
Revenue last 5Y
5.99%
Revenue Q/Q
56.58%
EPS Q/Q
-469.47%
-
-
-
-
SMA20
6.05%
SMA50
1.68%
SMA100
-1.34%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
6%
ROC
0.03%
Gross Margin
29%
Oper. Margin
6%
Profit Margin
7%
Payout
6%
Shs Outstand
38.98M
Shs Float
34.83M
-
-
-
-
Target Price
-
52W Range
26700.0-42500.0
52W High
-28.59%
52W Low
+13.67%
RSI
69
Rel Volume
-
Avg Volume
8.57K
Volume
Perf Week
3.58%
Perf Month
12.41%
Perf Quarter
-10.07%
Perf Half Y
-11.52%
-
-
-
-
Beta
1.0851
-
-
Volatility
408.58%, 887.16%
Prev Close
0.17%
Price
30350
Change
-1.14%
28513K.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 69.13K | 72.01K | 69.04K | 118.72K | 94.78K | |
Net income per share | 304.67 | 253.35 | 510.12 | 21.06K | 9.91K | |
Operating cash flow per share | 3.4K | 6.16K | 14.04K | 28.94K | -9.66K | |
Free cash flow per share | -865.76 | -388.73 | 8.52K | 20.58K | -25.35K | |
Cash per share | 9.13K | 13.76K | 24.25K | 116.45K | 89.11K | |
Book value per share | 34.97K | 36.11K | 54.16K | 116.67K | 111.23K | |
Tangible book value per share | 34.73K | 34.37K | 52.4K | 143.3K | 137.67K | |
Share holders equity per share | 34.97K | 36.11K | 54.16K | 116.67K | 111.23K | |
Interest debt per share | 47.87K | 58.71K | 41.66K | 28.25K | 38.47K | |
Market cap | 481.79B | 570.83B | 3061.29B | 1564.8B | 717.97B | |
Enterprise value | 1351.95B | 1517.25B | 3683.16B | 1795.91B | 1044.87B | |
P/E ratio | 79.92 | 113.68 | 341.1 | 4.22 | 3.75 | |
Price to sales ratio | 0.35 | 0.4 | 2.52 | 0.75 | 0.39 | |
POCF ratio | 7.15 | 4.67 | 12.39 | 3.07 | -3.85 | |
PFCF ratio | -28.13 | -74.09 | 20.43 | 4.32 | -1.47 | |
P/B Ratio | 0.7 | 0.8 | 3.21 | 0.76 | 0.33 | |
PTB ratio | 0.7 | 0.8 | 3.21 | 0.76 | 0.33 | |
EV to sales | 0.99 | 1.06 | 3.03 | 0.86 | 0.57 | |
Enterprise value over EBITDA | 9.88 | 8.98 | 17.42 | 2.81 | 3.07 | |
EV to operating cash flow | 20.07 | 12.42 | 14.91 | 3.53 | -5.6 | |
EV to free cash flow | -78.92 | -196.92 | 24.58 | 4.96 | -2.14 | |
Earnings yield | 0.01 | 0.01 | 0 | 0.24 | 0.27 | |
Free cash flow yield | -0.04 | -0.01 | 0.05 | 0.23 | -0.68 | |
Debt to equity | 1.32 | 1.58 | 0.74 | 0.24 | 0.34 | |
Debt to assets | 0.47 | 0.53 | 0.33 | 0.12 | 0.18 | |
Net debt to EBITDA | 6.36 | 5.6 | 2.94 | 0.36 | 0.96 | |
Current ratio | 1.21 | 1.1 | 1.43 | 2.56 | 2.38 | |
Interest coverage | 1.44 | 2.41 | 4.36 | 52.38 | 14.91 | |
Income quality | -4.1 | 24.32 | 0.97 | 1.9 | -0.81 | |
Dividend Yield | 0 | 0.01 | 0 | 0.02 | 0.09 | |
Payout ratio | 0 | 1.05 | 0.67 | 0.07 | 0.35 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Research and developement to revenue | 0.04 | 0.05 | 0.05 | 0.04 | 0.05 | |
Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | |
Capex to operating cash flow | -1.25 | -1.06 | -0.39 | -0.29 | 1.62 | |
Capex to revenue | -0.06 | -0.09 | -0.08 | -0.07 | -0.17 | |
Capex to depreciation | -0.95 | -1.26 | -0.99 | -1.58 | -3.31 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 15.48K | 14.35K | 24.93K | 235.1K | 157.48K | |
ROIC | -0.09 | 0.01 | 0.03 | 0.15 | 0.08 | |
Return on tangible assets | 0 | 0 | 0 | 0.09 | 0.05 | |
Graham Net | -36.82K | -42.21K | -24.15K | 64.03K | 49.94K | |
Working capital | 122.86B | 73.16B | 277.61B | 1697.41B | 1459.87B | |
Tangible asset value | 687.22B | 681.28B | 921.98B | 2522.32B | 2657.13B | |
Net current asset value | -508.08B | -620.98B | -237.75B | 1395.16B | 1281.92B | |
Invested capital | 1.32 | 1.58 | 0.74 | 0.24 | 0.34 | |
Average receivables | 206.38B | 193.21B | 214.25B | 316.36B | 353.94B | |
Average payables | 152.46B | 148.29B | 114.79B | 125.94B | 131.67B | |
Average inventory | 309.61B | 329.78B | 291.77B | 301.11B | 416.03B | |
Days sales outstanding | 53.9 | 47.17 | 73.33 | 67.89 | 63.7 | |
Days payables outstanding | 50.23 | 48.35 | 35.36 | 50.8 | 28.62 | |
Days of inventory on hand | 109.62 | 109.58 | 106.8 | 105.52 | 145.13 | |
Receivables turnover | 6.77 | 7.74 | 4.98 | 5.38 | 5.73 | |
Payables turnover | 7.27 | 7.55 | 10.32 | 7.19 | 12.75 | |
Inventory turnover | 3.33 | 3.33 | 3.42 | 3.46 | 2.51 | |
ROE | 0.01 | 0.01 | 0.01 | 0.18 | 0.09 | |
Capex per share | -4.27K | -6.55K | -5.52K | -8.36K | -15.69K |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 22.55K | 24.73K | 18.96K | 23.1K | 0 | |
Net income per share | 1.82K | 3.85K | 595.58 | -661 | 0 | |
Operating cash flow per share | 1.69K | 1.34K | -4.45K | -5.11K | 0 | |
Free cash flow per share | -2.38K | -4.14K | -12.79K | -12.36K | 0 | |
Cash per share | 91.04K | 89.11K | 92.32K | 94.66K | 0 | |
Book value per share | 107.54K | 111.23K | 111.56K | 132.4K | 0 | |
Tangible book value per share | 133.61K | 137.67K | 137.83K | 163.51K | 0 | |
Share holders equity per share | 107.54K | 111.23K | 111.56K | 132.4K | 0 | |
Interest debt per share | 35.52K | 37.95K | 52.6K | 61.88K | 0 | |
Market cap | 796.09B | 717.97B | 665.01B | 528.13B | 0 | |
Enterprise value | 1211.51B | 1044.87B | 1030.86B | 1019.42B | 0 | |
P/E ratio | 5.72 | 2.41 | 14.52 | -12.42 | 0 | |
Price to sales ratio | 1.84 | 1.5 | 1.82 | 1.42 | 0 | |
POCF ratio | 24.53 | 27.7 | -7.78 | -6.43 | 0 | |
PFCF ratio | -17.46 | -8.99 | -2.71 | -2.66 | 0 | |
P/B Ratio | 0.39 | 0.33 | 0.31 | 0.25 | 0 | |
PTB ratio | 0.39 | 0.33 | 0.31 | 0.25 | 0 | |
EV to sales | 2.8 | 2.19 | 2.83 | 2.75 | 0 | |
Enterprise value over EBITDA | 12.41 | 22.73 | 10.53 | 50.22 | 0 | |
EV to operating cash flow | 37.33 | 40.31 | -12.06 | -12.41 | 0 | |
EV to free cash flow | -26.56 | -13.09 | -4.19 | -5.13 | 0 | |
Earnings yield | 0.04 | 0.1 | 0.02 | -0.02 | 0 | |
Free cash flow yield | -0.06 | -0.11 | -0.37 | -0.38 | 0 | |
Debt to equity | 0.33 | 0.34 | 0.47 | 0.46 | 0 | |
Debt to assets | 0.18 | 0.18 | 0.24 | 0.24 | 0 | |
Net debt to EBITDA | 4.25 | 7.11 | 3.74 | 24.2 | 0 | |
Current ratio | 2.54 | 2.38 | 2.32 | 3.04 | 2.98 | |
Interest coverage | 19.62 | 4.09 | -1.45 | -1.55 | 0 | |
Income quality | 0.77 | 0.31 | -7.47 | 5.31 | 0 | |
Dividend Yield | 0.01 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.22 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.02 | 0.01 | 0.24 | 0.02 | 0.18 | |
Research and developement to revenue | 0.06 | 0.06 | 0.07 | 0.1 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Capex to operating cash flow | -2.41 | -4.08 | 1.88 | 1.42 | 0 | |
Capex to revenue | -0.18 | -0.22 | -0.44 | -0.31 | 0 | |
Capex to depreciation | -3.4 | -4.45 | -6.46 | -4.08 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 66.27K | 98.2K | 38.66K | 44.37K | 0 | |
ROIC | 0.02 | 0.01 | 0 | 0 | 0.03 | |
Return on tangible assets | 0.01 | 0.02 | 0 | 0 | 0.01 | |
Graham Net | 52.12K | 49.94K | 38.72K | 39.28K | 0 | |
Working capital | 1546.98B | 1459.87B | 1476.52B | 1602.88B | 1511.36B | |
Tangible asset value | 2563.11B | 2657.13B | 2648.99B | 2628.72B | 2700.63B | |
Net current asset value | 1327.31B | 1281.92B | 1087.12B | 989.74B | 860.83B | |
Invested capital | 0.33 | 0.34 | 0.47 | 0.46 | 0 | |
Average receivables | 310.8B | 307.57B | 306.41B | 309.16B | 162.35B | |
Average payables | 131.12B | 118.34B | 102.98B | 95.89B | 40.51B | |
Average inventory | 471.26B | 498.35B | 499.92B | 524.1B | 265.55B | |
Days sales outstanding | 61.57 | 60.2 | 72.5 | 78.7 | 0 | |
Days payables outstanding | 45.61 | 25.85 | 37.4 | 25.89 | 0 | |
Days of inventory on hand | 165.67 | 131.09 | 174.6 | 169.74 | 0 | |
Receivables turnover | 1.46 | 1.49 | 1.24 | 1.14 | 0 | |
Payables turnover | 1.97 | 3.48 | 2.41 | 3.48 | 0 | |
Inventory turnover | 0.54 | 0.69 | 0.52 | 0.53 | 0 | |
ROE | 0.02 | 0.03 | 0.01 | 0 | 0.02 | |
Capex per share | -4.07K | -5.48K | -8.34K | -7.25K | 0 |
28513K.KS Frequently Asked Questions
What is SK Chemicals Co.,Ltd. stock symbol ?
SK Chemicals Co.,Ltd. is a KR stock and trading under the symbol 28513K.KS
What is SK Chemicals Co.,Ltd. stock quote today ?
SK Chemicals Co.,Ltd. stock price is $30350 today.
Is SK Chemicals Co.,Ltd. stock public?
Yes, SK Chemicals Co.,Ltd. is a publicly traded company.